Martinelli Chiara, Pucci Carlotta, Ciofani Gianni
Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Pontedera (Pisa) 56025, Italy.
APL Bioeng. 2019 Mar 26;3(1):011502. doi: 10.1063/1.5079943. eCollection 2019 Mar.
Cancer accounts for millions of deaths every year and, due to the increase and aging of the world population, the number of new diagnosed cases is continuously rising. Although many progresses in early diagnosis and innovative therapeutic protocols have been already set in clinical practice, still a lot of critical aspects need to be addressed in order to efficiently treat cancer and to reduce several drawbacks caused by conventional therapies. Nanomedicine has emerged as a very promising approach to support both early diagnosis and effective therapy of tumors, and a plethora of different inorganic and organic multifunctional nanomaterials have been designed to meet the constant demand for new solutions in cancer treatment. Given their unique features and extreme versatility, nanocarriers represent an innovative and easily adaptable tool both for imaging and targeted therapy purposes, in order to improve the specific delivery of drugs administered to cancer patients. The current review reports an in-depth analysis of the most recent research studies aiming at developing both inorganic and organic materials for nanomedical applications in cancer diagnosis and therapy. A detailed overview of different approaches currently undergoing clinical trials or already approved in clinical practice is provided.
癌症每年导致数百万人死亡,并且由于世界人口的增长和老龄化,新诊断病例的数量持续上升。尽管早期诊断和创新治疗方案已在临床实践中取得了许多进展,但仍有许多关键问题需要解决,以便有效地治疗癌症并减少传统疗法带来的诸多弊端。纳米医学已成为一种非常有前景的方法,可支持肿瘤的早期诊断和有效治疗,并且已经设计了大量不同的无机和有机多功能纳米材料,以满足癌症治疗中对新解决方案的不断需求。鉴于其独特的特性和极高的通用性,纳米载体是一种创新且易于适应的工具,可用于成像和靶向治疗,以改善给予癌症患者的药物的特异性递送。本综述报告了对旨在开发用于癌症诊断和治疗的纳米医学应用的无机和有机材料的最新研究的深入分析。提供了当前正在进行临床试验或已在临床实践中获得批准的不同方法的详细概述。